This emdr was initially submitted on july 23, 2026, with a b4 report date of july 31, 2026.Following the fda production environment update on july 23, 2026, a validation change prevented acceptance of emdr files containing future-dated b4 report dates.Biohorizons was notified of this requirement on july 31, 2026.As a result, the original submission failed and is being resubmitted with a non-future-dated b4 report date to facilitate successful fda receipt and processing.